Chronic hepatitis C affects more than 3 million Americans and is a major cause of liver disease, cirrhosis, and liver cancer. New treatments now make it possible to cure almost all infected individuals. IAS-USA sponsors CME for physicians on the diagnosis and management of hepatitis C through live courses, web-based training, and journal articles.